SOPHiA GENETICS (SOPH) Cash from Financing Activities (2020 - 2026)

SOPHiA GENETICS has disclosed Cash from Financing Activities across 7 years of filings, most recently posting $54.0 million for Q2 2026.

• In Q2 2026, Cash from Financing Activities rose 60.98% year-over-year to $54.0 million; the TTM figure through Jun 2026 stood at $64.7 million (up 113.91% YoY), while the FY2025 annual figure was $30.2 million, up 206.15% from the prior year.
• Cash from Financing Activities came in at $54.0 million for Q2 2026 at SOPHiA GENETICS, up from $13.0 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $54.0 million in Q2 2026 to a low of -$2.0 million in Q3 2025.
• Average Cash from Financing Activities over 5 years is $5.7 million, with a median of -$599500.0 recorded in 2022.
• Year-over-year, Cash from Financing Activities tumbled 366.81% in 2023 and soared 2187.56% in 2024.
• Over 5 years, Cash from Financing Activities stood at -$580000.0 in 2022, then climbed by 11.72% to -$512000.0 in 2023, then tumbled by 128.12% to -$1.2 million in 2024, then jumped by 67.04% to -$385000.0 in 2025, then jumped by 14123.38% to $54.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $54.0 million in Q2 2026, $13.0 million in Q1 2026, and -$385000.0 in Q4 2025.